These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
52 related articles for article (PubMed ID: 25315500)
1. De novo alloreactive memory CD8+ T cells develop following allogeneic challenge when CNI immunosuppression is delayed. Hart-Matyas M; Gareau AJ; Hirsch GM; Lee TD Transpl Immunol; 2015 Jan; 32(1):23-8. PubMed ID: 25315500 [TBL] [Abstract][Full Text] [Related]
2. mTOR Inhibition Suppresses Posttransplant Alloantibody Production Through Direct Inhibition of Alloprimed B Cells and Sparing of CD8+ Antibody-Suppressing T cells. Avila CL; Zimmerer JM; Elzein SM; Pham TA; Abdel-Rasoul M; Bumgardner GL Transplantation; 2016 Sep; 100(9):1898-906. PubMed ID: 27362313 [TBL] [Abstract][Full Text] [Related]
3. Aortic allograft vasculopathy is mediated by CD8(+) T cells in Cyclosporin A immunosuppressed mice. Vessie EL; Hirsch GM; Lee TD Transpl Immunol; 2005 Oct; 15(1):35-44. PubMed ID: 16223671 [TBL] [Abstract][Full Text] [Related]
4. Cyclosporine immunosuppression does not prevent the production of donor-specific antibody capable of mediating allograft vasculopathy. Gareau AJ; Nashan B; Hirsch GM; Lee TD J Heart Lung Transplant; 2012 Aug; 31(8):874-80. PubMed ID: 22554675 [TBL] [Abstract][Full Text] [Related]
5. CD8(+) T cells mediate aortic allograft vasculopathy under conditions of calcineurin immunosuppression: role of IFN-gamma and CTL mediators. Nejat S; Zaki A; Hirsch GM; Lee TD Transpl Immunol; 2008 May; 19(2):103-11. PubMed ID: 18503885 [TBL] [Abstract][Full Text] [Related]
6. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways. Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307 [TBL] [Abstract][Full Text] [Related]
7. Splenic dendritic cell subsets prime and boost CD8 T cells and are involved in the generation of effector CD8 T cells. Behboudi S; Moore A; Hill AV Cell Immunol; 2004 Mar; 228(1):15-9. PubMed ID: 15203315 [TBL] [Abstract][Full Text] [Related]
8. Type 2 immune deviation has differential effects on alloreactive CD4+ and CD8+ T cells. Matesic D; Valujskikh A; Pearlman E; Higgins AW; Gilliam AC; Heeger PS J Immunol; 1998 Nov; 161(10):5236-44. PubMed ID: 9820495 [TBL] [Abstract][Full Text] [Related]
9. CD4+ TH1 cells generated by Ii-PADRE DNA at prime phase are important to induce effectors and memory CD8+ T cells. Park JY; Jin DH; Lee CM; Jang MJ; Lee SY; Shin HS; Chung YH; Kim KY; Kim SS; Lee WB; Shin YK; Lee WJ; Park YM; Kim D J Immunother; 2010 Jun; 33(5):510-22. PubMed ID: 20463596 [TBL] [Abstract][Full Text] [Related]
10. A color-coded reporter model to study the effect of immunosuppressants on CD8+ T-cell memory in antitumor and alloimmune responses. Rovira J; Sabet-Baktach M; Eggenhofer E; Lantow M; Koehl GE; Schlitt HJ; Campistol JM; Geissler EK; Kroemer A Transplantation; 2013 Jan; 95(1):54-62. PubMed ID: 23222894 [TBL] [Abstract][Full Text] [Related]
11. IFN-gamma and Fas/FasL pathways cooperate to induce medial cell loss and neointimal lesion formation in allograft vasculopathy. Hart-Matyas M; Nejat S; Jordan JL; Hirsch GM; Lee TD Transpl Immunol; 2010 Feb; 22(3-4):157-64. PubMed ID: 19895889 [TBL] [Abstract][Full Text] [Related]
12. Allospecific CD4+, Th1/Th2 and CD8+, Tc1/Tc2 populations in murine GVL: type I cells generate GVL and type II cells abrogate GVL. Fowler DH; Breglio J; Nagel G; Hirose C; Gress RE Biol Blood Marrow Transplant; 1996 Oct; 2(3):118-25. PubMed ID: 9199754 [TBL] [Abstract][Full Text] [Related]
13. 17beta-Estradiol increases the number of effector memory CD8+ lymphocytes in mice with contact hypersensitivity and among cultured splenocytes. Sakazaki F; Ueno H; Nakamuro K Immunopharmacol Immunotoxicol; 2010 Jun; 32(2):246-50. PubMed ID: 20128660 [TBL] [Abstract][Full Text] [Related]
14. Modulation of T cell homeostasis and alloreactivity under continuous FTY720 exposure. Metzler B; Gfeller P; Wieczorek G; Li J; Nuesslein-Hildesheim B; Katopodis A; Mueller M; Brinkmann V Int Immunol; 2008 May; 20(5):633-44. PubMed ID: 18343890 [TBL] [Abstract][Full Text] [Related]
15. Adoptive transfer of allogeneic liver sinusoidal endothelial cells specifically inhibits T-cell responses to cognate stimuli. Banshodani M; Onoe T; Shishida M; Tahara H; Hashimoto S; Igarashi Y; Tanaka Y; Ohdan H Cell Transplant; 2013; 22(9):1695-708. PubMed ID: 23050792 [TBL] [Abstract][Full Text] [Related]
16. Potential role of host effector memory CD8+ T cells in marrow rejection after mixed chimerism induction in cynomolgus monkeys. Setoguchi K; Kishimoto H; Kobayashi S; Shimmura H; Ishida H; Toki D; Suzuki T; Ohnuki K; Tate Y; Fujioka S; Abe R; Tanabe K Transpl Immunol; 2010 Aug; 23(4):194-203. PubMed ID: 20624462 [TBL] [Abstract][Full Text] [Related]
17. Central role of tumor-associated CD8+ T effector/memory cells in restoring systemic antitumor immunity. Kilinc MO; Gu T; Harden JL; Virtuoso LP; Egilmez NK J Immunol; 2009 Apr; 182(7):4217-25. PubMed ID: 19299720 [TBL] [Abstract][Full Text] [Related]
18. Determination of the functional status of alloreactive T cells by interferon-gamma kinetics. Kwun J; Knechtle SJ; Hu H Transplantation; 2006 Feb; 81(4):590-8. PubMed ID: 16495808 [TBL] [Abstract][Full Text] [Related]
19. The major histocompatibility complex (MHC) of the secondary transplant tissue donor influences the cross-reactivity of alloreactive memory cells. Wang F; Chen J; Shao W; Kang X; Xu S; Xia J; Dai H; Peng Y; Thorlacius H; Xing J; Qi Z Scand J Immunol; 2011 Mar; 73(3):190-7. PubMed ID: 21204892 [TBL] [Abstract][Full Text] [Related]
20. Endogenous superantigens in allogeneic bone marrow transplant recipients rapidly and selectively expand donor T cells which can produce IFN-gamma. Jones MS; Riley R; Hamilton BL; Paupe J; Perez D; Levy RB Bone Marrow Transplant; 1994 Nov; 14(5):725-35. PubMed ID: 7889005 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]